Trial Profile
Multicenter, Randomized, Double-blind, Placebo-controlled Study of ATX-101 (Sodium Deoxycholate Injection) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area (SMF) Using Magnetic Resonance Imaging (MRI) and a Battery of Clinician- and Subject-reported Measurements.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Jun 2015
Price :
$35
*
At a glance
- Drugs Deoxycholic acid (Primary)
- Indications Subcutaneous fat disorders
- Focus Therapeutic Use
- Sponsors Kythera Biopharmaceuticals
- 11 Jun 2014 New trial record